Semaglutide and tirzepatide DXA anchors Wilding JPH, et al
Case Conclusion Initial combination therapy with metformin, paired with a DPP-4 inhibitor or an SGLT2 inhibitor (or a combination of a DPP-4 inhibitor and an SGLT2 inhibitor in patients with a contraindication or intolerance to metformin [81] in accordance with the current AACE algorithm), would be reasonable treatment options for this young patient who does not have overt CVD, but who does have related risk factors including hypertension, elevated HbA1c levels, and excess body weight
Eligibility is determined by a licensed provider based on each patient's individual health intake
In contrast, no significant difference was observed in AKT mRNA expression among the experimental groups (KruskalWallis H = 5.947, p = 0.114
The finding from IQVIAs In-depth Patient Insights in Obesity 4 that many patients feel obesity is not taken seriously by primary care doctors suggests that this AOM inertia among GPs and IMs stems from a broader challenge: these doctors are not keeping up with the pace of change in this condition
The brains were removed and post-fixed in 4% PFA overnight, and cryoprotected in 30% sucrose until the tissue sank